Filter By Industry
Filter By Tag

Newsroom

Advanced Cancer Therapeutics Press releases

1 - 6 of 6 Press Releases

Advanced Cancer Therapeutics’ PFK-158 Featured in CEO/CFO Magazine
Dec 15, 2014
Announces MD Anderson and UT Health Science Center San Antonio Added as Clinical Trial Sites

Advanced Cancer Therapeutics’ PFK-158 Selected
Nov 25, 2014
as One of Informa and Kantar Health 2014 Top 10 Most Interesting Oncology Projects to Watch

ACT Enters Phase I Human Clinical Trials with First-in-Class Anti-Cancer Drug Candidate
Jun 04, 2014
Louisville, KY – June 4, 2014 - Advanced Cancer Therapeutics (ACT), a privately held company dedicated to bringing new anti-cancer therapies to market, announced today that it has begun clinical trials of PFK-158, a small molecule therapeutic candidate...

ACT Awarded Phase I SBIR Grant to Develop Anti-cancer Drug for Novel Cancer
Oct 11, 2012
Advanced Cancer Therapeutics (ACT) announced that it has been awarded a $158,000 Phase I Small Business Innovative Research grant by the National Cancer Institute to support the development of a novel therapeutic agent for brain cancer.

U.S. Granted Patent 8,088,385 B2 Strengthens Advanced Cancer Therapeutics’ Anti-cancer Portfo
Apr 03, 2012
Advanced Cancer Therapeutics (ACT) has been granted U.S. Patent 8,088,385 B2 titled “PFKFB3 inhibitor for the treatment of a Proliferative Cancer” by the United States Patent Office.

Advanced Cancer Therapeutics CEO to Present Preclinical Data on Cancer Metabolism Drug
Oct 19, 2011
Advanced Cancer Therapeutics CEO to Present Preclinical Data on Cancer Metabolism Drug at MidAmerica Healthcare Venture Forum


Advanced Cancer Therapeutics RSS Feed